89bio, Inc. - Common Stock (NQ:ETNB)

14.84 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 29, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about 89bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

89bio to Participate in the H.C. Wainwright 6th Annual NASH Investor Conference

October 13, 2022

From 89bio, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 16, 2022

Via Benzinga

Analyst Ratings for 89bio ↗

September 14, 2022

Over the past 3 months, 7 analysts have published their opinion on 89bio (NASDAQ:ETNB) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's...

Via Benzinga

7 Analysts Have This to Say About 89bio ↗

September 14, 2022

89bio (NASDAQ:ETNB) has observed the following analyst ratings within the last quarter:

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 13, 2022

Via Benzinga

89bio's Pegozafermin Data Shows Improved Liver Fat, Glycemic Control ↗

August 26, 2022

Via Benzinga

Analysts Are Bullish On 89bio's NASH Data Slated For Early Next Year ↗

August 18, 2022

Via Benzinga

Analyst Ratings for 89bio ↗

August 17, 2022

Within the last quarter, 89bio (NASDAQ:ETNB) has observed the following analyst ratings:

Via Benzinga

Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday ↗

September 14, 2022

Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX...

Via Benzinga

US Stocks Open Lower After Inflation Report, Dow Dips 700 Points ↗

September 13, 2022

U.S. stocks traded sharply lower this morning, following the release of inflation data for August

Via Benzinga

6 Analysts Have This to Say About 89bio ↗

August 17, 2022

Analysts have provided the following ratings for 89bio (NASDAQ:ETNB) within the last quarter:

Via Benzinga

Where 89bio Stands With Analysts ↗

August 17, 2022

Analysts have provided the following ratings for 89bio (NASDAQ:ETNB) within the last quarter:

Via Benzinga

Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session ↗

September 13, 2022

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

September 13, 2022

Investors can start off the day with a breakdown of the biggest pre-market stock movers for Tuesday and the news moving those shares!

Via InvestorPlace

Expert Ratings for 89bio ↗

July 28, 2022

Analysts have provided the following ratings for 89bio (NASDAQ:ETNB) within the last quarter:

Via Benzinga

This Analyst Thinks 89Bio's Pegozafermin Data Has Exceeded Expectations ↗

July 11, 2022

Via Benzinga

89bio Posts Promising Pegozafermin Data For Severe Hypertriglyceridemia ↗

June 29, 2022

89bio Inc (NASDAQ: ETNB)

Via Benzinga

Recap Of Friday's Biotech Catalysts - End Of the Day Summary ↗

August 26, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 26, 2022

Via Benzinga

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary ↗

August 18, 2022

Via Benzinga

89bio Shares Climb After Concluding Enrolment In Mid-Stage NASH Study ↗

August 18, 2022

89bio (NASDAQ: ETNB) has completed enrollment in ENLIVEN, the Phase 2b trial of pegozafermin for the treatment of non-alcoholic steatohepatitis (NASH).

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 17, 2022

Via Benzinga

Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday ↗

August 15, 2022

Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.

Via Benzinga

Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session ↗

August 12, 2022

Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year.

Via Benzinga

Recap: 89bio Q2 Earnings ↗

August 11, 2022

89bio (NASDAQ:ETNB) reported its Q2 earnings results on Thursday, August 11, 2022. Here's what investors need to know about the announcement. Earnings 89bio missed estimated earnings by 14.95%,...

Via Benzinga

The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill ↗

July 07, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Disney To $125? Here's The Biggest Price Target Changes For Thursday ↗

June 30, 2022

Stifel cut SMART Global Holdings, Inc. (NASDAQ: SGH) price target from $45 to $32. SMART Global shares fell 13.1% to $17.62 in pre-market trading.

Via Benzinga

5 Analysts Have This to Say About 89bio ↗

June 29, 2022

Over the past 3 months, 5 analysts have published their opinion on 89bio (NASDAQ:ETNB) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's...

Via Benzinga

The Daily Biotech Pulse: Eli Lilly Modifies COVID-19 Treatment Pact, Oyster Point Outlines Restructuring Plan, Icosavax Posts Interim RSV Vaccine Data ↗

June 29, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

U.S. Stock Futures Edge Higher; GDP Report In Focus ↗

June 29, 2022

Pre-open movers

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.